Respiratory infections demand fast, accurate diagnosis across dozens of pathogens, but clinicians face a hard trade-off: simple point-of-care tests cover only a few bugs, while comprehensive panels need lab infrastructure. This report maps the multiplex molecular testing landscape—the platforms, the patents, the supply chains and the structural bottlenecks that shape access and surge capacity.
Three pages from this report, open in full. The rest opens when you own it.
Eight parts, the same tabs you get when you own the report.
5 use cases
The technology recommended for each, with the alternatives.
+ 2 more
10 classes
Every class compared, with its patent trend and leading players.
+ 7 more
5 sectors
Mapped against the classes, with who sits in each.
Published November 2026 · © 2026 Berkeley FIT LLC. All rights reserved.
+ 2 more
156 companies
Searchable and filterable by sector, class and relevance.
+ 153 more
2,018 products
The products behind the companies, grouped by class.
+ 2,015 more
1,949 patents
Dominant and emerging holders for each mechanism of action.
+ 7 more
6 pathways
What each means for timelines and cost.
2 catalogs
Take the data with you.